Semin intervent Radiol 2019; 36(02): 097-103
DOI: 10.1055/s-0039-1688422
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Complications of Percutaneous Renal Biopsy

Kenaz Bakdash
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of Colorado, Anschutz Medical Center, Aurora, Colorado
,
Kristofer M. Schramm
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of Colorado, Anschutz Medical Center, Aurora, Colorado
,
Aparna Annam
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of Colorado, Anschutz Medical Center, Aurora, Colorado
,
Matthew Brown
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of Colorado, Anschutz Medical Center, Aurora, Colorado
,
Kimi Kondo
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of Colorado, Anschutz Medical Center, Aurora, Colorado
,
Jonathan D. Lindquist
1   Division of Vascular and Interventional Radiology, Department of Radiology, University of Colorado, Anschutz Medical Center, Aurora, Colorado
› Author Affiliations
Further Information

Publication History

Publication Date:
22 May 2019 (online)

Abstract

Percutaneous renal biopsy is widely used for diagnosis, prognosis, and management of nephropathies. Complications may arise after renal biopsy, most commonly in the form of bleeding. Efforts should be taken to optimize modifiable risk factors such as hypertension, thrombocytopenia, and coagulopathy prior to the procedure. Unmodifiable risk factors such as poor renal function, gender, and underlying histologic diagnosis may be used to identify high-risk patients. Delayed presentation of bleeding complications is common, and close clinical follow-up is crucial.

 
  • References

  • 1 Iversen P, Brun C. Aspiration biopsy of the kidney. Am J Med 1951; 11 (03) 324-330
  • 2 Gwyn NB. Biopsies and the completion of certain surgical procedures. Can Med Assoc J 1923; 13 (11) 820-823
  • 3 Kark RM, Muehrcke RC. Biopsy of kidney in prone position. Lancet 1954; 266 (6821): 1047-1049
  • 4 Madaio MP. Renal biopsy. Kidney Int 1990; 38 (03) 529-543
  • 5 Korbet SM. Percutaneous renal biopsy. Semin Nephrol 2002; 22 (03) 254-267
  • 6 Korbet SM, Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies. Am J Nephrol 2014; 39 (02) 153-162
  • 7 Kriegshauser JS, Patel MD, Young SW, Chen F, Eversman WG, Chang YH. Risk of bleeding after native renal biopsy as a function of preprocedural systolic and diastolic blood pressure. J Vasc Interv Radiol 2015; 26 (02) 206-212
  • 8 Shidham GB, Siddiqi N, Beres JA. , et al. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton) 2005; 10 (03) 305-310
  • 9 McWilliams JP, Kee ST. Native renal biopsy: the perfect storm. J Vasc Interv Radiol 2015; 26 (02) 212-213
  • 10 Hogan JJ, Mocanu M, Berns JS. The native kidney biopsy: update and evidence for best practice. Clin J Am Soc Nephrol 2016; 11 (02) 354-362
  • 11 Tabatabai S, Sperati CJ, Atta MG. , et al. Predictors of complication after percutaneous ultrasound-guided kidney biopsy in HIV-infected individuals: possible role of hepatitis C and HIV co-infection. Clin J Am Soc Nephrol 2009; 4 (11) 1766-1773
  • 12 Corapi KM, Chen JL, Balk EM, Gordon CE. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 2012; 60 (01) 62-73
  • 13 Marwah DS, Korbet SM. Timing of complications in percutaneous renal biopsy: what is the optimal period of observation?. Am J Kidney Dis 1996; 28 (01) 47-52
  • 14 Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15 (01) 142-147
  • 15 Xu DM, Chen M, Zhou FD, Zhao MH. Risk factors for severe bleeding complications in percutaneous renal biopsy. Am J Med Sci 2017; 353 (03) 230-235
  • 16 Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 2005; 9 (01) 40-45
  • 17 Lees JS, McQuarrie EP, Mordi N, Geddes CC, Fox JG, Mackinnon B. Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clin Kidney J 2017; 10 (04) 573-577
  • 18 Prasad N, Kumar S, Manjunath R. , et al. Real-time ultrasound-guided percutaneous renal biopsy with needle guide by nephrologists decreases post-biopsy complications. Clin Kidney J 2015; 8 (02) 151-156
  • 19 Waldo B, Korbet SM, Freimanis MG, Lewis EJ. The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys. Nephrol Dial Transplant 2009; 24 (08) 2433-2439
  • 20 Diaz-Buxo JA, Donadio Jr JV. Complications of percutaneous renal biopsy: an analysis of 1,000 consecutive biopsies. Clin Nephrol 1975; 4 (06) 223-227
  • 21 Christensen J, Lindequist S, Knudsen DU, Pedersen RS. Ultrasound-guided renal biopsy with biopsy gun technique--efficacy and complications. Acta Radiol 1995; 36 (03) 276-279
  • 22 Torres Muñoz A, Valdez-Ortiz R, González-Parra C, Espinoza-Dávila E, Morales-Buenrostro LE, Correa-Rotter R. Percutaneous renal biopsy of native kidneys: efficiency, safety and risk factors associated with major complications. Arch Med Sci 2011; 7 (05) 823-831
  • 23 Whittier WL, Gashti C, Saltzberg S, Korbet S. Comparison of native and transplant kidney biopsies: diagnostic yield and complications. Clin Kidney J 2018; 11 (05) 616-622
  • 24 Patel IJ, Davidson JC, Nikolic B. , et al; Standards of Practice Committee, with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012; 23 (06) 727-736
  • 25 Biondi-Zoccai GG, Lotrionte M, Agostoni P. , et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006; 27 (22) 2667-2674
  • 26 Baffour FI, Hickson LJ, Stegall MD. , et al. Effects of aspirin therapy on ultrasound-guided renal allograft biopsy bleeding complications. J Vasc Interv Radiol 2017; 28 (02) 188-194
  • 27 Mackinnon B, Fraser E, Simpson K, Fox JG, Geddes C. Is it necessary to stop antiplatelet agents before a native renal biopsy?. Nephrol Dial Transplant 2008; 23 (11) 3566-3570
  • 28 Pieper M, Schmitz J, McBane R. , et al. Bleeding complications following image-guided percutaneous biopsies in patients taking clopidogrel—a retrospective review. J Vasc Interv Radiol 2017; 28 (01) 88-93
  • 29 Manno C, Bonifati C, Torres DD, Campobasso N, Schena FP. Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. Am J Kidney Dis 2011; 57 (06) 850-855
  • 30 Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 2007; 82 (08) 731-735
  • 31 Mannucci PM, Remuzzi G, Pusineri F. , et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 1983; 308 (01) 8-12
  • 32 Manno C, Strippoli GF, Arnesano L. , et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66 (04) 1570-1577
  • 33 Moledina DG, Luciano RL, Kukova L. , et al. Kidney biopsy-related complications in hospitalized patients with acute kidney disease. Clin J Am Soc Nephrol 2018; 13 (11) 1633-1640
  • 34 Constantin A, Brisson M-L, Kwan J, Proulx F. Percutaneous US-guided renal biopsy: a retrospective study comparing the 16-gauge end-cut and 14-gauge side-notch needles. J Vasc Interv Radiol 2010; 21 (03) 357-361
  • 35 Hergesell O, Felten H, Andrassy K, Kühn K, Ritz E. Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant 1998; 13 (04) 975-977
  • 36 Babaei Jandaghi A, Lebady M, Zamani A-A, Heidarzadeh A, Monfared A, Pourghorban R. A randomised clinical trial to compare coaxial and noncoaxial techniques in percutaneous core needle biopsy of renal parenchyma. Cardiovasc Intervent Radiol 2017; 40 (01) 106-111
  • 37 Fisi V, Mazák I, Degrell P. , et al. Histological diagnosis determines complications of percutaneous renal biopsy: a single-center experience in 353 patients. Kidney Blood Press Res 2012; 35 (01) 26-34
  • 38 Korbet SM, Gashti CN, Evans JK, Whittier WL. Risk of percutaneous renal biopsy of native kidneys in the evaluation of acute kidney injury. Clin Kidney J 2018; 11 (05) 610-615
  • 39 Morgan TA, Chandran S, Burger IM, Zhang CA, Goldstein RB. Complications of ultrasound-guided renal transplant biopsies. Am J Transplant 2016; 16 (04) 1298-1305
  • 40 Redfield RR, McCune KR, Rao A. , et al. Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsy. Transpl Int 2016; 29 (02) 167-172
  • 41 Chen TK, Gelber AC, Witter FR, Petri M, Fine DM. Renal biopsy in the management of lupus nephritis during pregnancy. Lupus 2015; 24 (02) 147-154
  • 42 Piccoli GB, Daidola G, Attini R. , et al. Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. BJOG 2013; 120 (04) 412-427
  • 43 Afshin A, Forouzanfar MH, Reitsma MB. , et al; GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377 (01) 13-27